These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 31405169)

  • 1. The Abnormal CD4+T Lymphocyte Subset Distribution and Vbeta Repertoire in New-onset Rheumatoid Arthritis Can Be Modulated by Methotrexate Treament.
    Monserrat J; Bohórquez C; Gómez Lahoz AM; Movasat A; Pérez A; Ruíz L; Díaz D; Chara L; Sánchez AI; Albarrán F; Sanz I; Álvarez-Mon M
    Cells; 2019 Aug; 8(8):. PubMed ID: 31405169
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methrotexate Treatment Inmunomodulates Abnormal Cytokine Expression by T CD4 Lymphocytes Present in DMARD-Naïve Rheumatoid Arthritis Patients.
    Monserrat Sanz J; Bohórquez C; Gómez AM; Movasat A; Pérez A; Ruíz L; Diaz D; Sánchez AI; Albarrán F; Sanz I; Álvarez-Mon M
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32961930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of a Type 2-Polarized T Cell Phenotype With Methotrexate Nonresponse in Patients With Rheumatoid Arthritis.
    Slauenwhite D; McAlpine SM; Hanly JG; Malik A; Haidl ID; Marshall JS; Issekutz TB
    Arthritis Rheumatol; 2020 Jul; 72(7):1091-1102. PubMed ID: 32039570
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In active chronic rheumatoid arthritis, dipeptidyl peptidase IV density is increased on monocytes and CD4(+) T lymphocytes.
    Ellingsen T; Hornung N; Møller BK; Hjelm-Poulsen J; Stengaard-Pedersen K
    Scand J Immunol; 2007 Oct; 66(4):451-7. PubMed ID: 17850590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential effect of methotrexate on the increased CCR2 density on circulating CD4 T lymphocytes and monocytes in active chronic rheumatoid arthritis, with a down regulation only on monocytes in responders.
    Ellingsen T; Hornung N; Møller BK; Poulsen JH; Stengaard-Pedersen K
    Ann Rheum Dis; 2007 Feb; 66(2):151-7. PubMed ID: 16905577
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rheumatoid Arthritis Patients, Both Newly Diagnosed and Methotrexate Treated, Show More DNA Methylation Differences in CD4
    Guderud K; Sunde LH; Flåm ST; Mæhlen MT; Mjaavatten MD; Lillegraven S; Aga AB; Evenrød IM; Norli ES; Andreassen BK; Franzenburg S; Franke A; Haavardsholm EA; Rayner S; Gervin K; Lie BA
    Front Immunol; 2020; 11():194. PubMed ID: 32117312
    [No Abstract]   [Full Text] [Related]  

  • 7. CD39 positive regulatory T cell frequency as a biomarker of treatment response to methotrexate in rheumatoid arthritis.
    Gupta V; Katiyar S; Singh A; Misra R; Aggarwal A
    Int J Rheum Dis; 2018 Aug; 21(8):1548-1556. PubMed ID: 30146748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methotrexate Treatment of Newly Diagnosed RA Patients Is Associated With DNA Methylation Differences at Genes Relevant for Disease Pathogenesis and Pharmacological Action.
    Guderud K; Sunde LH; Flåm ST; Mæhlen MT; Mjaavatten MD; Norli ES; Evenrød IM; Andreassen BK; Franzenburg S; Franke A; Rayner S; Gervin K; Lie BA
    Front Immunol; 2021; 12():713611. PubMed ID: 34867944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of conventional DMARD and biological therapies on CD4+ cell subsets in rheumatoid arthritis: a follow-up study.
    Szalay B; Vásárhelyi B; Cseh A; Tulassay T; Deák M; Kovács L; Balog A
    Clin Rheumatol; 2014 Feb; 33(2):175-85. PubMed ID: 23934385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD45RA-Foxp3(high) activated/effector regulatory T cells in the CCR7 + CD45RA-CD27 + CD28+central memory subset are decreased in peripheral blood from patients with rheumatoid arthritis.
    Matsuki F; Saegusa J; Miyamoto Y; Misaki K; Kumagai S; Morinobu A
    Biochem Biophys Res Commun; 2013 Sep; 438(4):778-83. PubMed ID: 23747721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methotrexate preferentially affects Tc1 and Tc17 subset of CD8 T lymphocytes.
    Sandhu A; Ahmad S; Kaur P; Bhatnagar A; Dhawan V; Dhir V
    Clin Rheumatol; 2019 Jan; 38(1):37-44. PubMed ID: 29464523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An immunological biomarker to predict MTX response in early RA.
    Ponchel F; Goëb V; Parmar R; El-Sherbiny Y; Boissinot M; El Jawhari J; Burska A; Vital EM; Harrison S; Conaghan PG; Hensor E; Emery P
    Ann Rheum Dis; 2014 Nov; 73(11):2047-53. PubMed ID: 23989988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The immunosuppressive effect of methotrexate in active rheumatoid arthritis patients vs. its stimulatory effect in nonactive patients, as indicated by cytometric measurements of CD4+ T cell subpopulations.
    Herman S; Zurgil N; Langevitz P; Ehrenfeld M; Deutsch M
    Immunol Invest; 2004 Aug; 33(3):351-62. PubMed ID: 15495793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differences in IDO1
    Malik AE; Slauenwhite D; McAlpine SM; Hanly JG; Marshall JS; Issekutz TB
    Front Immunol; 2024; 15():1352251. PubMed ID: 38840915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Up-regulated dipeptidyl-peptidase IV (CD26) on monocytes was unaffected by effective DMARD treatment in early steroid and DMARD-naive rheumatoid arthritis.
    Ellingsen T; Hansen I; Thorsen J; Kuno Møller B; Tarp U; Jacobsen S; Lund Hetland M; Vestergaard A; Hørslev-Petersen K; Stengaard-Pedersen K
    Clin Exp Rheumatol; 2012; 30(1):58-63. PubMed ID: 22273590
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of polysaccharide fractions isolated from Caltha palustris L. on the cellular immune response in collagen-induced arthritis (CIA) in mice. A comparison with methotrexate.
    Suszko A; Obmińska-Mrukowicz B
    J Ethnopharmacol; 2013 Jan; 145(1):109-17. PubMed ID: 23123796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methotrexate reduces vaccine-specific immunoglobulin levels but not numbers of circulating antibody-producing B cells in rheumatoid arthritis after vaccination with a conjugate pneumococcal vaccine.
    Kapetanovic MC; Nagel J; Nordström I; Saxne T; Geborek P; Rudin A
    Vaccine; 2017 Feb; 35(6):903-908. PubMed ID: 28081972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methotrexate treatment affects effector but not regulatory T cells in juvenile idiopathic arthritis.
    Bulatović Ćalasan M; Vastert SJ; Scholman RC; Verweij F; Klein M; Wulffraat NM; Prakken BJ; van Wijk F
    Rheumatology (Oxford); 2015 Sep; 54(9):1724-34. PubMed ID: 25877908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monocyte populations as markers of response to adalimumab plus MTX in rheumatoid arthritis.
    Chara L; Sánchez-Atrio A; Pérez A; Cuende E; Albarrán F; Turrión A; Chevarria J; Sánchez MA; Monserrat J; de la Hera A; Prieto A; Sanz I; Diaz D; Alvarez-Mon M
    Arthritis Res Ther; 2012 Jul; 14(4):R175. PubMed ID: 22838733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characteristics of T-Cell Receptor Repertoire for Differential Response to Methotrexate Treatment for Rheumatoid Arthritis.
    Zhao T; Zhang Q; Wen Q; Liu S; Niu Z; Qu Y; Wang Y; Ding Q; Wei P; Li L; Kong T; Fu P; Qian S; Wang K; Wu X; Zheng J
    Immunol Invest; 2024 Oct; 53(7):1113-1124. PubMed ID: 39140790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.